Traditional Chinese medicine combined with Moxibustion in the treatment of “long-COVID”: A protocol for systematic review and meta-analysisArticle Published on 2022-10-282022-11-16 Journal: Medicine [Category] meta-analysis, [키워드] benefit carried China Chinese composed COVID-19 database Efficacy and safety eight evaluate evaluated Evidence exclusion criteria Inclusion Infrastructure international public health journal knowledge lack Meta-analysis moxibustion patients with COVID-19 prevalent protocol Randomized controlled trial Research risk Science screened symptoms of COVID-19 systematic review technology Traditional Chinese medicine treat Treatment was used Web of Science [DOI] 10.1097/MD.0000000000031447 PMC 바로가기
Efficacy of ensitrelvir against SARS-CoV-2 in a delayed-treatment mouse modelArticle Published on 2022-10-282022-11-15 Journal: Journal of Antimicrobial Chemotherapy [Category] COVID19(2023년), SARS, 진단, 치료제, [키워드] acute respiratory syndrome Administered age anti-SARS-CoV-2 Antiviral Antiviral compound antiviral efficacy body weight Body weight loss caused Cell clinical development coronavirus coronavirus disease correlated COVID-19 demonstrated development dose dose-dependent manner effective Efficacy evaluated expression general treatment Health in vivo increased survival Inflammatory Intervention lung Lung inflammation Lung pathology mice mouse-adapted SARS-CoV-2 nucleocapsid protein pandemic patients with COVID-19 Post-infection protease pulmonary lesion quantified reduced reduced viral load RNA RT-qPCR Safe SARS-CoV-2 SARS-COV-2 infection Support suppressed survival target the SARS-CoV-2 titre treat Treatment Viral RNA was used were infected [DOI] 10.1093/jac/dkac257 PMC 바로가기
Multi-target mechanisms against coronaviruses of constituents from Chinese Dagang Tea revealed by experimental and docking studies실험 및 도킹 연구를 통해 밝혀진 중국 Dagang Tea 성분의 코로나바이러스에 대한 다중 표적 메커니즘Article Published on 2022-10-282022-09-11 Journal: Journal of ethnopharmacology [Category] COVID19(2023년), SARS, 치료제, [키워드] Analysis analysis antibody antiviral activity Antiviral effect betulinic acid Chemical profile China Chinese Cold colds Compound coronavirus coronavirus Coronaviruses CPE Cytopathic effect demonstrated docking docking analysis docking study Efficacy enzyme Enzyme inhibition eriodictyol Eurya evaluated exhibited experiment Fever fevers flavonoids Guangdong HCoV-OC43 herbal tea immunofluorescence in vitro infected cells Influenza inhibitory effect Inhibitory effects material mechanism Microscopic monomer naringenin OC43 optical performed PLPro Potential treatment potential treatments Prevent quercetin reduction SARS-CoV-2 tea Traditional Chinese medicine transmission electron microscopy treat Treatment viral infections Virtual screening virus particle virus particles [DOI] 10.1016/j.jep.2022.115528 PMC 바로가기 [Article Type] Article
Genomic Epidemiology and Serology Associated with a SARS-CoV-2 R.1 Variant Outbreak in New JerseyArticle Published on 2022-10-262022-11-15 Journal: mBio [Category] COVID19(2023년), SARS, 변종, 유전자 메커니즘, 진단, 치료기술, [키워드] acute respiratory syndrome antibody antibody resistance attack rate B.1.351 B.1.526 Care caused characteristic Clinical use collected Community Complete coronavirus COVID-19 Critical E484K mutation Evidence Examining exhibit exhibited hcp Health highlight individual infected individuals Infection Inpatient Lineage loss of activity monoclonal antibody Mutation N-terminal domain neutralization capacity Neutralizing antibody response neutralizing capacity New nosocomial NTD outbreak P.1 Patient plasma positive professional professionals proportion pseudovirus psychiatric facility Receptor binding domain reported reverse transcription robust SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 variant sera Spike protein Symptom symptomatic COVID-19 disease tested the SARS-CoV-2 the United State treat vaccinated individual vaccinated individuals vaccination Vaccine variant variants of concern variants of concern. VOCs wild type [DOI] 10.1128/mbio.02141-22 PMC 바로가기
Dual Monoclonal Antibodies on Sars-Cov-2 Alpha and Delta Variants: Clinical and Virological EfficacyArticle Published on 2022-10-262022-11-15 Journal: Microbiology Spectrum [Category] COVID19(2023년), SARS, 변종, 유전자 메커니즘, 진단, 치료제, [키워드] analysis antibodies antibody antiviral efficacy association bamlanivimab/etesevimab casirivimab/imdevimab clinical conducted Course COVID-19 Delta Dual therapy Efficacy France genomic glycoprotein growth high risk highlight joint management monoclonal monoclonal antibodies monoclonal antibody Mutation mutation selection. neutralization omicron overlap Paris Patient patients died patients treated Prevent Protein resistance mechanism SARS-CoV-2 SARS-CoV-2 antibody SARS-CoV-2 variant SARS-CoV-2-positive patients selected selective severe COVID-19 spike Spread the Spike therapy treat Treatment treatment initiation variant variants viral genome Viral load viral mutation was done [DOI] 10.1128/spectrum.02152-22 PMC 바로가기
Utilization of the Abbott SARS-CoV-2 IgG II Quant Assay To Identify High-Titer Anti-SARS-CoV-2 Neutralizing Plasma against Wild-Type and Variant SARS-CoV-2 VirusesArticle Published on 2022-10-262022-11-15 Journal: Microbiology Spectrum [Category] COVID19(2023년), SARS, 변종, 진단, [키워드] 95% confidence interval Abbott Abbott SARS-CoV-2 IgG acute respiratory syndrome Analysis approach approach authorization BAU Beta binding antibody unit Canada CCP characterized Chicago Chicago IL clinical trial convalescent convalescent plasma coronavirus COVID-19 COVID-19 convalescent plasma Cutoff Delta disease course drug Emergency EUA evaluated Evidence experiment FDA food Gamma highest hospitalized patient Humoral immunity identify IgG immune IMPROVE Mann-Whitney U method comparisons Neutralization assay Neutralizing neutralizing antibody outcome Patient patient group plaque reduction neutralization plaque reduction neutralization. plasma PRNT quantitative determination required SARS-CoV-2 SARS-CoV-2 antibody selected significantly specimen tested the SARS-CoV-2 time-consuming treat United State utilization variant VLP VoC wild-type with COVID-19 [DOI] 10.1128/spectrum.02811-22 PMC 바로가기
Screening and evaluation of cytotoxicity and antiviral effects of secondary metabolites from water extracts of Bersama abyssinica against SARS-CoV-2 DeltaArticle Published on 2022-10-262022-11-15 Journal: BMC Complementary Medicine and Therapies [Category] COVID19(2023년), SARS, 변종, 치료제, [키워드] Acetate activities Analysis Anti-viral anti-viral agents antioxidant antiviral activity Antiviral effect Asthma bacterial respiratory infections Bersama abyssinica bioactive compounds bronchitis BSL-3 component Compound Concentration conducted coronavirus Coviba Dawa COVID-19 COVID-19 symptoms cytotoxicity Delta delta variant determine ether experiment fraction in vitro ingredient Isolation level 3 medication methanol Phenols polar procedure propionate Registered respiratory disorder SARS-CoV-2 Screening Secondary Metabolite Standard Tanzania temperature tested the SARS-CoV-2 Traditional Traditional medicine. treat VERO E6 cells viral pathogen virus was done was obtained water [DOI] 10.1186/s12906-022-03754-3 PMC 바로가기
Narrative review on century of respiratory pandemics from Spanish flu to COVID-19 and impact of nanotechnology on COVID-19 diagnosis and immune system boostingArticle Published on 2022-10-242022-11-15 Journal: Virology Journal [Category] 치료제, [키워드] Analysis analyzed Antiviral Bioavailability clinical manifestations Corona COVID-19 COVID-19 diagnosis Cytokines determinant drugs facemasks Factor Host hygiene immune immune system immunopathology IMPROVE include Intervention investigated medical intervention MERS morbidity and mortality Nanotechnology narrative pandemic Pandemics pathogenicity Pregnancy quarantine reservoirs respiratory Respiratory pandemics respiratory viral diseases response SARS-CoV-2 Spanish flu Spanish flu. Symptom therapy Toxicity Transmission treat Vaccines virus viruses [DOI] 10.1186/s12985-022-01902-2 PMC 바로가기
Potential Therapeutic Approach of Melatonin against Omicron and Some Other Variants of SARS-CoV-2Article Published on 2022-10-162022-11-15 Journal: Molecules [Category] COVID19(2023년), SARS, 변종, 치료제, [키워드] Anti-inflammatory antioxidant antiviral drug applied caused clinical trial Combination contagious coronavirus COVID-19 COVID-19 disease COVID-19 severity disease Diseases drug effective Efficacy experiment Immunity immunomodulatory effects Infection melatonin mutations omicron Omicron variant (B.529) Other outbreak Outbreaks over oxidative oxidative stress Potential Prevent reduce reducing safety profile SARS-CoV-2 severe symptom severity shown significant effect the disease therapeutic Therapeutic approach therapeutic approach. therapeutic drug therapy treat Treatment unique Vaccine variant [DOI] 10.3390/molecules27206934 PMC 바로가기
Small-Molecule RAF265 as an Antiviral Therapy Acts against PEDV InfectionArticle Published on 2022-10-152022-11-15 Journal: Viruses [Category] COVID19(2023년), SARS, 치료제, [키워드] Act acute diarrhea anticancer Antiviral antiviral strategy cause caused cellular cellular translation Concentration coronavirus cytoskeleton. drug effective epidemic diarrhea family Coronaviridae high mortality host cell inhibited inhibitor inhibitory activity magnitude Newborn PEDV pseudotyped RAF265 reduced reduced viral load Replication shown starting point translation treat Vero cells viral entry viral infection Viral vector virus vomiting [DOI] 10.3390/v14102261 PMC 바로가기